• Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS) coronavirus 2 has affected 188 countries worldwide with a global death toll of over half a million; • Patients with valvular heart disease are also at an increased risk of adverse outcomes from coronavirus disease-2019; • Prognosis of patients with the combination of COVID 19 and severe valvular heart disease is poor; • This is the first reported case of MitraClip insertion in a patient with severe COVID 19 infection. This procedure assisted in the patient’s recovery relieving his cardiac burden and pulmonary edema enabling him to undergo colorectal surgery.
Mitraclip insertion to hasten recovery from severe COVID-19 disease